company background image
MRK logo

Merck NYSE:MRK Stock Report

Last Price

US$104.83

Market Cap

US$262.9b

7D

-1.5%

1Y

1.9%

Updated

30 Oct, 2024

Data

Company Financials +

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$136.19
FV
23.0% undervalued intrinsic discount
5.74%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Updated narrative

Merck & Co., Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Merck
Historical stock prices
Current Share PriceUS$104.83
52 Week HighUS$134.63
52 Week LowUS$99.80
Beta0.40
11 Month Change-7.69%
3 Month Change-7.90%
1 Year Change1.93%
33 Year Change18.21%
5 Year Change25.92%
Change since IPO9,218.22%

Recent News & Updates

Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat

Oct 25

Recent updates

Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat

Oct 25

Market Still Lacking Some Conviction On Merck & Co., Inc. (NYSE:MRK)

Oct 15
Market Still Lacking Some Conviction On Merck & Co., Inc. (NYSE:MRK)

Merck Is At Support And Should Go Higher (Technical Analysis)

Oct 07

Merck Appears Ready To Return To June Highs (Technical Analysis)

Sep 14

Merck's Change To Profit Guidance Provides An Opportunity

Sep 01

Merck: Buy This Bargain Before It's Gone

Aug 12

Merck & Co., Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 01
Merck & Co., Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Shareholder Returns

MRKUS PharmaceuticalsUS Market
7D-1.5%-3.7%0.5%
1Y1.9%22.6%36.8%

Return vs Industry: MRK underperformed the US Pharmaceuticals industry which returned 22.6% over the past year.

Return vs Market: MRK underperformed the US Market which returned 36.8% over the past year.

Price Volatility

Is MRK's price volatile compared to industry and market?
MRK volatility
MRK Average Weekly Movement2.4%
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.1%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.0%

Stable Share Price: MRK has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: MRK's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
189171,000Rob Daviswww.merck.com

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names.

Merck & Co., Inc. Fundamentals Summary

How do Merck's earnings and revenue compare to its market cap?
MRK fundamental statistics
Market capUS$262.94b
Earnings (TTM)US$13.74b
Revenue (TTM)US$62.48b

19.3x

P/E Ratio

4.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MRK income statement (TTM)
RevenueUS$62.48b
Cost of RevenueUS$15.13b
Gross ProfitUS$47.35b
Other ExpensesUS$33.62b
EarningsUS$13.74b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 31, 2024

Earnings per share (EPS)5.42
Gross Margin75.79%
Net Profit Margin21.98%
Debt/Equity Ratio86.6%

How did MRK perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

55%

Payout Ratio